iso-VQA-ACC incorporates an isomerized peptide motif linked to an ACC fluorophore for sensitive protease detection. Sequence rearrangement influences cleavage efficiency and fluorescence restoration after hydrolysis. Researchers examine its specificity toward select proteases. Applications include substrate optimization, kinetic characterization, and mechanistic enzymology.
iso-VQA-ACC is a synthetic peptide substrate designed for the sensitive and specific detection of protease activity, particularly in biochemical and enzymology research. Structurally, it features an isomeric modification of the VQA (valine-glutamine-alanine) motif conjugated to the ACC (7-amino-4-carbamoylmethylcoumarin) fluorophore. The incorporation of the ACC moiety enables fluorescence-based readouts upon proteolytic cleavage, making iso-VQA-ACC a valuable tool for real-time monitoring of enzymatic reactions. Its tailored sequence and fluorescent properties support a wide range of applications in the characterization of protease specificity, inhibitor screening, and mechanistic studies within peptide research.
Protease activity assays: iso-VQA-ACC is widely utilized as a fluorogenic substrate in quantitative assays for protease activity. Upon enzymatic cleavage at the peptide bond adjacent to the ACC group, the non-fluorescent substrate releases a highly fluorescent ACC product, which can be measured in real time using standard fluorescence detection platforms. This mechanism allows for sensitive and kinetic monitoring of proteolytic events in purified enzyme preparations, cell lysates, or complex biological mixtures. Researchers leverage this property to determine enzyme kinetics, substrate preferences, and to compare the catalytic efficiency of different protease isoforms.
Enzyme inhibitor screening: In drug discovery and biochemical research, iso-VQA-ACC serves as an essential probe for high-throughput screening of protease inhibitors. By measuring changes in fluorescence in the presence of candidate compounds, scientists can rapidly identify and characterize molecules that block or modulate proteolytic activity. The substrate's robust signal-to-noise ratio and compatibility with microplate-based formats facilitate its integration into automated screening workflows, enabling efficient evaluation of inhibitor potency and selectivity.
Substrate specificity profiling: The unique sequence and isomeric configuration of iso-VQA-ACC make it suitable for dissecting the substrate recognition properties of various proteases. Researchers employ the peptide to map the cleavage preferences of target enzymes, elucidate sequence determinants of substrate binding, and explore the structural basis of enzyme-substrate interactions. These insights are crucial for understanding protease function, guiding rational inhibitor design, and advancing fundamental enzymology.
Mechanistic enzymology studies: The fluorogenic nature of iso-VQA-ACC supports detailed mechanistic investigations into protease action. By enabling continuous, real-time monitoring of substrate turnover, the peptide allows for the precise determination of kinetic parameters such as Km and kcat. This facilitates the study of enzyme mechanisms under varying conditions, including pH, temperature, and the presence of cofactors or allosteric modulators, yielding a comprehensive understanding of proteolytic processes.
Peptide-based assay development: The versatility of iso-VQA-ACC extends to the development and optimization of custom peptide-based assays. Its defined structure and predictable cleavage profile provide a reliable foundation for designing multiplexed or tailored assays for different protease targets. Analytical laboratories and research groups utilize the substrate to establish reproducible workflows for monitoring enzymatic activity in diverse experimental setups, supporting both fundamental research and applied biotechnological applications.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.